Investor Alert

Nov. 12, 2020, 12:09 p.m. EST

Top Penny Stocks To Watch Right Now; 5 Biotech Stocks To Know

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Nov 12, 2020 (Penny Stocks via COMTEX) -- Are These Biotech Penny Stocks On Your Watch List Right Now?

While the traders digest the latest news in the stock market today, penny stocks remain a focal point. These cheap stocks are some of the most exciting especially during times where volatility might be lacking in the broader markets. Where does this put you and your approach?

Are you more of an investor looking for buy and hold opportunities or do you want a quick flip? Even if you're somewhere in between certain penny stocks can offer different opportunities. So keep that in mind. Not all penny stocks will be good to invest in and not all penny stocks are suited for quick trades.

With that, certain industries and sectors might also lend a hand to your style. Take biotechnology stocks, for instance. Some of the "blue chip stocks" in the space might offer a longer-term, investment opportunity due to their size and business scope. Meanwhile, other small cap stocks within the sector might be higher volatility opportunities.

[Read More] What Are Good Penny Stocks To Buy Right Now? 4 For Your Watch List?

Will they only be good for day trading? As we've seen this year, not all penny stocks breakout and break down quickly. Some of the most actively traded, higher-priced biotech stocks like Novavax and even Pacific Biosciences were trading at penny stock levels earlier this year.

What's a key to finding top penny stocks ? Well, for short-term, strong technicals and momentum are a few staples. Longer-term, investors will look at different fundamental aspects. Whatever the case might be, the end goal is to profit from these stocks.

  1. GT Biopharma Inc. ( GTBP Stock Report )

  2. Corbus Pharmaceuticals ( CRBP Stock Report )

  3. Northwest Biotherapeutics ( NWBO Stock Report )

  4. BioCryst Pharmaceuticals ( BCRX Stock Report )

  5. Verastem Oncology Inc. ( VSTM Stock Report )

Biotech Penny Stocks To Watch #1: GT Biopharma Inc.

One of the frequent things that biotech companies will undertake when they have seen progress in their pipelines is attend industry conferences. Some of these conferences carry with them large groups of attendees, investors, and funds looking for novel treatment technologies. In the case of GT Biopharma Inc. its lead treatment, GTB-3550 has been a key point of focus for the last month or so.

It's targeting the treatment of patients with acute myeloid leukemia and is currently in Phase I/II trials. The initial focus is on dosing and the efficacy & tolerability of the treatment. At the end of September, the company gave a Dose Level 3 Update on a patient completing a 25mcg/kg/day dose. It showed a decrease in AML blast levels from 18% to 12% in the bone marrow.

But this update is important for another reason and it has to do with what was announced on Thursday. Not only was an abstract on GTB-3550 chosen for presentation at a major upcoming industry conference, but early information was also released this month; The American Society of Hematology Annual meeting

Here's what was revealed in the online ASH meeting program : Though no objective responses were seen at the initial low dose cohorts tested, these early data suggest proof of principle that the drug has immune activity in humans. Subsequent patients given higher dose levels will determine if NK cell proliferation translates into clinical efficacy.

Since this was in 4 patients - 2 dosed at 5mcg/kg/day and 2 at 10mcg/kg/day - it doesn't seem to include the newer information released by the company on its Dose Level 3 at 25mcg. Currently 7 patients have been enrolled, two at 5 mcg/kg/day, two at 10 mcg/kg/day, two at 25 mcg/kg/day, and one at 50 mcg/kg/day. Considering that patient showed a favorable response, what could that mean for the road ahead for GTB-3550?

Biotech Penny Stocks To Watch #2: Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals has been in recovery mode after taking a huge hit earlier this year. The penny stock was actually trading over $9 a share as of the beginning of September. Look at any chart and you'll see what has transpired in a very short timeframe. This goes back to what I was discussing above with risk/reward. Even though CRBP stock wasn't considered a penny stock, it reacted that way in light of some bad Phase 3 results.

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.